| Clifford Vincent Morris, MD | |
|
228 Johnson Creek Drive, Chester, VA 23836 | |
| (804) 530-1044 | |
| (877) 718-0972 |
| Full Name | Clifford Vincent Morris |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 35 Years |
| Location | 228 Johnson Creek Drive, Chester, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558382994 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 0101048464 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Randolph Medical Center | Hopewell, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbia-hca John Randolph, Inc | 0244206753 | 9 |
| Morris Cardiovascular And Risk Reduction Center Pc | 6103098546 | 4 |
| Ivyrehab Sept, Llc | 7911990908 | 1137 |
News Archive
Esaote, one of the world's leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable "green" ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment's notice.
Redspin, Inc., a leading provider of HIPAA security risk assessments and penetration testing services, today released an IT security advisory specifically for senior executives in the healthcare industry.
A bacterial molecule that initially signals to animals that they have been invaded must be wiped out by a special enzyme before an infected animal can regain full health, researchers at UT Southwestern Medical Center have found.
A Yale Cancer Center clinical trial combining the immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as preoperative treatment for early stage triple negative breast cancer disclosed a 71% pathologic complete response to the combination treatment in the initial phase I trial.
Contrary to treatment guidelines for high-risk bladder cancer, chemotherapy before or after surgery is not commonly used in routine clinical practice. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
› Verified 5 days ago
| Entity Name | Columbia-hca John Randolph, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952762650 PECOS PAC ID: 0244206753 Enrollment ID: O20040907000809 |
News Archive
Esaote, one of the world's leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable "green" ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment's notice.
Redspin, Inc., a leading provider of HIPAA security risk assessments and penetration testing services, today released an IT security advisory specifically for senior executives in the healthcare industry.
A bacterial molecule that initially signals to animals that they have been invaded must be wiped out by a special enzyme before an infected animal can regain full health, researchers at UT Southwestern Medical Center have found.
A Yale Cancer Center clinical trial combining the immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as preoperative treatment for early stage triple negative breast cancer disclosed a 71% pathologic complete response to the combination treatment in the initial phase I trial.
Contrary to treatment guidelines for high-risk bladder cancer, chemotherapy before or after surgery is not commonly used in routine clinical practice. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
› Verified 5 days ago
| Entity Name | Morris Cardiovascular And Risk Reduction Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467734863 PECOS PAC ID: 6103098546 Enrollment ID: O20111007000427 |
News Archive
Esaote, one of the world's leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable "green" ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment's notice.
Redspin, Inc., a leading provider of HIPAA security risk assessments and penetration testing services, today released an IT security advisory specifically for senior executives in the healthcare industry.
A bacterial molecule that initially signals to animals that they have been invaded must be wiped out by a special enzyme before an infected animal can regain full health, researchers at UT Southwestern Medical Center have found.
A Yale Cancer Center clinical trial combining the immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as preoperative treatment for early stage triple negative breast cancer disclosed a 71% pathologic complete response to the combination treatment in the initial phase I trial.
Contrary to treatment guidelines for high-risk bladder cancer, chemotherapy before or after surgery is not commonly used in routine clinical practice. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
› Verified 5 days ago
| Entity Name | Bon Secours Medical Group Richmond Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477112225 PECOS PAC ID: 8022440056 Enrollment ID: O20191113002170 |
News Archive
Esaote, one of the world's leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable "green" ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment's notice.
Redspin, Inc., a leading provider of HIPAA security risk assessments and penetration testing services, today released an IT security advisory specifically for senior executives in the healthcare industry.
A bacterial molecule that initially signals to animals that they have been invaded must be wiped out by a special enzyme before an infected animal can regain full health, researchers at UT Southwestern Medical Center have found.
A Yale Cancer Center clinical trial combining the immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as preoperative treatment for early stage triple negative breast cancer disclosed a 71% pathologic complete response to the combination treatment in the initial phase I trial.
Contrary to treatment guidelines for high-risk bladder cancer, chemotherapy before or after surgery is not commonly used in routine clinical practice. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clifford Vincent Morris, MD 228 Johnson Creek Drive, Chester, VA 23836 Ph: (804) 530-1044 | Clifford Vincent Morris, MD 228 Johnson Creek Drive, Chester, VA 23836 Ph: (804) 530-1044 |
News Archive
Esaote, one of the world's leading manufacturers of medical diagnostic systems, is launching MyLab™Gamma, a best in class, highly-portable "green" ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, 30th August - 3rd September). Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment - at a moment's notice.
Redspin, Inc., a leading provider of HIPAA security risk assessments and penetration testing services, today released an IT security advisory specifically for senior executives in the healthcare industry.
A bacterial molecule that initially signals to animals that they have been invaded must be wiped out by a special enzyme before an infected animal can regain full health, researchers at UT Southwestern Medical Center have found.
A Yale Cancer Center clinical trial combining the immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as preoperative treatment for early stage triple negative breast cancer disclosed a 71% pathologic complete response to the combination treatment in the initial phase I trial.
Contrary to treatment guidelines for high-risk bladder cancer, chemotherapy before or after surgery is not commonly used in routine clinical practice. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
› Verified 5 days ago
Dr. Yinan Chou, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 12600 Iron Bridge Rd, Chester, VA 23831 Phone: 804-796-2371 Fax: 804-796-2371 | |
Gohar M Abbasi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1714 E Hundred Rd, Suite 101, Chester, VA 23836 Phone: 804-530-5293 Fax: 804-530-5295 | |
Mohammad Farooq, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1714 E Hundred Rd Ste 101, Chester, VA 23836 Phone: 804-590-6750 | |
Dr. Sujatha P Vuyyuru, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 110 Old Bermuda Hundred Rd, Chester, VA 23836 Phone: 804-530-9966 | |
Dr. Edward Kwodwo Boakye, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 12407 Inverness Way, Chester, VA 23836 Phone: 703-768-9660 | |
Gregory K Lemite, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1714 E Hundred Rd, Ste 104, Chester, VA 23836 Phone: 804-681-0556 Fax: 804-410-4619 |